Application | Comment | Organism |
---|---|---|
medicine | useful role of SKI-1/S1P in controlling cholesterol synthesis, particularly in the presence of endoplasmic reticulum stress. SKI-1/S1P inhibition may be a potential tool for the treatment of alcohol-induced liver steatosis | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
overexpression of proSKI variants in HepG2 cells | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
R130A/K131A | proSKI variant that exhibits no basic residue at the P4 position, has no effect on HMG-CoA reductase mRNA levels | Homo sapiens |
R134E | proSKI variant that lacks autocatalytic primary cleavage site RSLK, most efficient inhibitor of HMG-CoA reductase expression | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
additional information | SKI-1/S1P inhibition by overexpression of proSKI variants, results in reduced cholesterol synthesis and mRNA levels of the rate-limiting enzymes HMG-CoA reductase and squalene epoxidase in the cholesterol synthetic pathway. Inhibitory effect is maintained in the presence of homocysteine-induced endoplasmic reticulum stress. SKI-1/S1P inhibition also affects glycolysis and citric acid cycle | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
endoplasmic reticulum | - |
Homo sapiens | 5783 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
SKI-1/S1P | - |
Homo sapiens |